Geode Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-513,937
| Closed | -$24.7M | – | 4202 |
|
|
2020
Q1 | $24.7M | Sell |
513,937
-11,647
| -2% | -$559K | 0.01% | 1153 |
|
|
2019
Q4 | $24.7M | Buy |
525,584
+10,207
| +2% | +$479K | 0.01% | 1418 |
|
|
2019
Q3 | $12.2M | Buy |
515,377
+68,389
| +15% | +$1.62M | ﹤0.01% | 1804 |
|
|
2019
Q2 | $13.4M | Buy |
446,988
+75,500
| +20% | +$2.27M | ﹤0.01% | 1737 |
|
|
2019
Q1 | $8.32M | Buy |
371,488
+63,974
| +21% | +$1.43M | ﹤0.01% | 2021 |
|
|
2018
Q4 | $5.6M | Buy |
307,514
+123,539
| +67% | +$2.25M | ﹤0.01% | 2151 |
|
|
2018
Q3 | $3.33M | Buy |
183,975
+38,510
| +26% | +$697K | ﹤0.01% | 2615 |
|
|
2018
Q2 | $1.45M | Buy |
145,465
+31,428
| +28% | +$313K | ﹤0.01% | 3025 |
|
|
2018
Q1 | $605K | Buy |
114,037
+29,818
| +35% | +$158K | ﹤0.01% | 3335 |
|
|
2017
Q4 | $715K | Buy |
84,219
+7,435
| +10% | +$63.1K | ﹤0.01% | 3223 |
|
|
2017
Q3 | $1.12M | Buy |
76,784
+1,647
| +2% | +$24K | ﹤0.01% | 3076 |
|
|
2017
Q2 | $1.41M | Buy |
75,137
+4,274
| +6% | +$80.1K | ﹤0.01% | 2927 |
|
|
2017
Q1 | $1.51M | Buy |
70,863
+5,522
| +8% | +$118K | ﹤0.01% | 2802 |
|
|
2016
Q4 | $992K | Buy |
+65,341
| New | +$992K | ﹤0.01% | 2994 |
|